Target intelligence / Profile preview

Mitoguardin 1 (MIGA1)

Target
MIGA1
Molecular classification
Other
01

Overview

Mitoguardin 1 (MIGA1) is a mitochondrial outer-membrane protein crucial for the regulation of mitochondrial fusion, maintaining mitochondrial morphology, and establishing contacts between mitochondria and the endoplasmic reticulum (ERMCSs). MIGA1 promotes mitochondrial fusion through stabilization of mitochondrial phospholipase D and interacts with ER-localized proteins to regulate dynamic ER-mitochondria tethering. Genetic knockout models reveal its essential roles in female reproductive biology, including luteinization and progesterone production by ovarian granulosa cells, through control of mitochondrial structure and steroidogenic function. MIGA1 also connects mitochondria and autophagy, specifically mediating autophagosome-lysosome fusion and maintaining autophagic flux. Dysfunction of MIGA1 has been linked to neurodegeneration via impaired autophagy and mitochondrial function, and fusion events involving FAM73A (the gene encoding MIGA1) have been observed in cancer genomics databases, though no direct therapeutic targeting or pharmacological inhibitors are known for this protein. Thus, MIGA1 is primarily classified as a mitochondrial structural/regulatory protein with emerging importance in cell biology and disease, but not currently a direct drug target.

Other names
Mitoguardin 1MIGA1FAM73AFLJ35093Protein FAM73Afamily with sequence similarity 73, member A
02

Biological functions

Mitochondrial fusionRegulation of mitochondrial morphologyAutophagy regulationStabilization of mitochondrial phospholipase DMaintenance of ER-mitochondria contact sites (ERMCS)Steroidogenesis in ovarian granulosa cellsCell survival/apoptosis regulation
03

Disease associations

Neurodegenerative diseaseReproductive dysfunctionOther

Beyond the preview

Go deeper on Mitoguardin 1 (MIGA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitoguardin 1 (MIGA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call